These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 39247201)

  • 1. HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis.
    Chen YZ; Meng ZS; Xiang ZL
    Front Immunol; 2024; 15():1415435. PubMed ID: 39247201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
    Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M
    J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.
    Chen J; Yuan Q; Guan H; Cui Y; Fu C; Wei T; Liu K
    Front Immunol; 2024; 15():1461424. PubMed ID: 39346916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights.
    Li Y; Chen Y; Wang D; Wu L; Li T; An N; Yang H
    Front Immunol; 2024; 15():1442722. PubMed ID: 39081317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.
    Liu H; Xu L; Yue S; Su H; Chen X; Liu Q; Li H; Liang H; Chen X; He J; Ding Z; Zhang B
    Cancer Commun (Lond); 2024 Sep; 44(9):1018-1041. PubMed ID: 39030964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns.
    Wang C; Yang G; Feng G; Deng C; Zhang Q; Chen S
    Front Immunol; 2024; 15():1410603. PubMed ID: 39044829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma's prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response.
    Abulihaiti Z; Li W; Yang L; Zhang H; Du A; Tang N; Lu Y; Zeng J
    Mol Biol Rep; 2024 Aug; 51(1):905. PubMed ID: 39133347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.
    Chen J; Feng W; Sun M; Huang W; Wang G; Chen X; Yin Y; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Gastroenterology; 2024 Jul; 167(2):264-280. PubMed ID: 38417530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma.
    Zhao Y; Chen C; Chen K; Sun Y; He N; Zhang X; Xu J; Shen A; Zhao S
    Sci Rep; 2024 May; 14(1):12163. PubMed ID: 38806553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression.
    Liu Q; Niu R; Ye Y; Li J
    J Gene Med; 2024 Sep; 26(9):e3723. PubMed ID: 39228142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity.
    Fan R; Liu F; Gong Q; Liu D; Tang S; Shen D
    Front Immunol; 2024; 15():1393801. PubMed ID: 38660302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of S100A6/S100A11 in T-Cell Immune Regulatory in HCC Revealed by Single Cell RNA-seq.
    Zhou R; Pei B; Li X; Zhang X
    Technol Cancer Res Treat; 2024; 23():15330338241252610. PubMed ID: 38766816
    [No Abstract]   [Full Text] [Related]  

  • 15. CD74 facilitates immunotherapy response by shaping the tumor microenvironment of hepatocellular carcinoma.
    Cheng J; Li J; Jiang X; Ma X; Li B; Zhai H; Luo X; Zhou Y; Wu J; Zhang Z; Chen S; Wang Y
    Mol Med; 2024 Aug; 30(1):116. PubMed ID: 39118044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High ratio of resident to exhausted CD4 + T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma.
    Zuo A; Lv J; Jia W; Ba Y; Liu S; Zhang Y; Weng S; Xu H; Liu L; Wang L; Han X; Liu Z
    BMC Cancer; 2024 Sep; 24(1):1152. PubMed ID: 39289669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotic catastrophe heterogeneity: implications for prognosis and immunotherapy in hepatocellular carcinoma.
    Mao Z; Gao Z; Long R; Guo H; Chen L; Huan S; Yin G
    Front Immunol; 2024; 15():1409448. PubMed ID: 39015573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POSTN
    Wang H; Liang Y; Liu Z; Zhang R; Chao J; Wang M; Liu M; Qiao L; Xuan Z; Zhao H; Lu L
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39067872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.